Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Osiris Sells Osteocel: Up To $137M For Pipeline

May 08 2008

• By Randall Osborne

Related Content

Amgen Will Launch Palifermin In Late January Under Brand Name Kepivance

Dec 15 2004

Osiris Stem Cell Knee Therapy Misses Endpoint

Feb 13 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window